Global Clinical Trials Support Services Market 2022-2028: Efficiency of Support Services in Overcoming the Barriers Encountered while Conducting Clinical Trials Bolsters Adoption

03 Mar 2023
www.prnewswire.com
Clinical StudyPhase 2
DUBLIN, March 2, 2023 /PRNewswire/ -- The "Global Clinical Trials Support Services Market 2022-2028" report has been added to
ResearchAndMarkets.com's offering.
MARKET OUTLOOK
The publisher's report puts forth that the global clinical trials support services market would register growth at a CAGR of 7.84% during the forecast phase of 2022-2028.
The rise in the incidence of diseases has majorly increased the demand for clinical trials support services, which is expected to drive the market growth. Further, the efficiency of support services in overcoming the barriers encountered while conducting clinical trials is another key factor supporting growth.
On the other hand, the delays in receiving regulatory approval for carrying out clinical trials due to stringent regulations are hindering the growth process. Moreover, the disadvantages associated with the use of open-source software are also negatively impacting market progress.
However, the increasing demand for pharmaceuticals & vaccines, along with the growing number of strategic acquisitions by market players, are expected to open up new growth opportunities for the clinical trial support services market.
REGIONAL OUTLOOK
The global market for clinical trials support services encompasses North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the leading region in the global market, and held the largest market share in 2021. Most key players in the clinical trials support services market, such as IQVIA, Parexel, and Charles River Laboratories, among others, are based in the United States. This largely benefits the North American market.
Whereas, the high population of the Asia-Pacific, especially Asia, adds an advantage to the market in this region. This is because researchers gain access to a large number of potential trial participants. The Asia-Pacific is expected to witness the fastest growth in the global market over the considered period.
Key Topics Covered:
1. Global Clinical Trials Support Services Market - Summary
2. Industry Outlook
2.1. Impact of Covid-19 on the Clinical Trials Support Services Market
2.2. Key Insights
2.2.1. Key Players' Promising Collaborations
2.2.2. Increase in Screening Tests
2.3. Porter'S Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Key Buying Impact Analysis
2.4.1. Performance
2.4.2. Ease of Use
2.4.3. Security
2.4.4. Cost Effectiveness
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Industry Components
2.8. Regulatory Framework
2.9. Key Market Strategies
2.9.1. Acquisitions
2.9.2. Product Launches
2.9.3. Contracts & Agreements
2.9.4. Investments & Expansions
2.10. Market Drivers
2.10.1. Need to Overcome the Barriers in Clinical Trials
2.10.2. Rise in Trials Due to Increased Disease Incidence
2.11. Market Challenges
2.11.1. Delayed Approval Due to Stringent Regulatory Framework
2.11.2. Use of Open-Source Software
2.12. Market Opportunities
2.12.1. Increasing Demand for Vaccines and Pharmaceuticals
2.12.2. Data Management Service Expected to Witness Notable Growth
2.12.3. Acquisitions in the Clinical Trials Support Services Market
3. Global Clinical Trials Support Services Market Outlook - by Phase Type
3.1. Phase I
3.2. Phase Ii
3.3. Phase Iii
3.4. Phase Iv
4. Global Clinical Trials Support Services Market Outlook - by Service
4.1. Clinical Trial Site Management
4.2. Administrative Services
4.3. Patient Recruitment Management
4.4. Regulatory Services
4.5. Data Management
4.6. Other Services
5. Global Clinical Trials Support Services Market Outlook - by Sponsor
5.1. Pharmaceutical & Biopharmaceutical Companies
5.3. Other Sponsors
6. Global Clinical Trials Support Services Market - Regional Outlook
7. Competitive Landscape
7.1. Iqvia
7.5. Labcorp Drug Development
7.6. Clinipace
7.7. Kcr
7.9. Medpace
7.10. Alcura
7.11. Psi Cro
7.12. Worldwide Clinical Trials
7.15. Advanced Clinical
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.2. Sources of Data
8.3. Research Methodology
A selection of companies mentioned in this report includes
Labcorp Drug Development
Clinipace
Alcura
Worldwide Clinical Trials
Advanced Clinical
For more information about this report visit https://www.researchandmarkets.com/r/pu7gir
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.